Female engineer leaves mark on university and energy industry

Female engineer leaves mark on university and energy industry

“Welcome woman and gentlemen.” Valerie von Schramm nevertheless remembers listening to people words and phrases from some 40 decades back when attending conferences with her graduate school friends at McMaster University in Hamilton, Ontario, Canada. She also remembers those people uncomfortable times right away following that cordial greeting, when every person would flip to seem at her, the only feminine in the home.

Those people sometimes a little bit overwhelming, Valerie didn’t enable people uneasy moments outline or deter her. Rather, she powered forward. Just after earning a bachelor’s degree in utilized chemistry from McMaster, she went on to turn out to be the initially female to graduate from the university with a doctorate in chemical engineering!

As we proceed celebrating Women’s Historical past Thirty day period, today we shine the light on Dr. Valerie von Schramm.

Valerie came to Texas in 1987. Her first complete-time job in San Antonio was with the Texas Air Control Board, where she was the sole engineer and executed environmental tests and inspections throughout 30 South Texas counties. For the duration of her time with the Air Regulate Board, she labored closely with CPS Energy’s Environmental team. Quick-forward 13 years, Valerie arrived to work for CPS Strength as part of the Environmental crew in September 2000. Her 22-year occupation at the organization has centered around technological innovation and innovation, beginning with that assignment with the Environmental group. There, she managed the company’s Electrical Ability Study Institute (EPRI) portfolio and began research work in Distributed Era, which is electric power created at or near the website wherever it’s applied.

By 2014, she served on innovation groups at the corporation and productively obtained federal funding for exploration initiatives similar to gas cells, merged warmth and ability, strength effective residences and a microgrid. She afterwards joined the Products & Expert services team, working with electricity efficiency and thermostat sellers as element of our prosperous Conserve for Tomorrow Vitality Approach (Phase) application. Valerie upcoming labored in the Grid Transformation & Organizing area, largely managing the Electric powered Car Action Enabled System. In modern months, she rejoined the Items & Products and services staff, exactly where she’s aspect of a new innovation group that will be assessing new technologies for prospective adoption by CPS Energy or its customers. Together with this operate, Valerie serves on quite a few condition and federal technologies advisory committees.

Continue to keep studying to study extra about Valerie, her experiences and achievements, which includes some remarkable EPRI awards!

Valerie von Schramm with her sons Derek and Nigel

Q: Was there everything in certain that drew you to the discipline of engineering?

Valerie: My dad appreciated to tinker and make matters. I had no brothers, so I was his helper when he was operating on the car or truck engine or updating the electrical/plumbing program in our 100-12 months-outdated residence. In high college, I had a amazing chemistry instructor as a mentor. When I entered McMaster, engineering hardly ever crossed my head –  in the early 70s, it was just something that most ladies did not do. I took just one engineering study course as an elective and discovered I exceled at it and liked it. My professors encouraged me to transfer into engineering, so I concluded out my utilized chemistry degree taking all my optional classes from engineering and then acquired an advanced degree in chemical engineering.

Q: Have you and/or your team gained any special awards or honors in the earlier handful of yrs?

Valerie: I’ve been on teams that gained two EPRI Technological innovation Transfer Awards. Final year, we were regarded for exploration do the job on Future Generation Heat Pumps. Conventional warmth pumps are efficient but have challenges creating ample heat when temperatures drop underneath 35 degrees. Advanced warmth pumps are equipped to generate heat at temperatures as chilly as degrees, which would profit our grid by cutting down electric consumption during significant chilly snaps.

In 2016, we attained the award for investigation function relevant to Working day-Ahead Solar Forecasting, which assists figure out how a lot ability can be envisioned from solar vitality the future working day and can help in era planning.

Q: What improvements have you viewed at CPS Electricity about the a long time?

Valerie: When I joined in 2000, quite a few of the systems that we are applying now, this kind of as photo voltaic panels, ended up in their infancy. The speed of technological modify in the marketplace is accelerating and this is shifting our do the job setting. Our new get the job done ecosystem will demand us to be flexible, adaptable and have robust interaction competencies.

Q. Explain to us about how your legacy of services to CPS Vitality is continuing.

Valerie: My son Nigel will work for CPS Energy, in Overhead Construction Providers as a Metrics Program Manager. He’s aiding overhead development with strengthening economic tracking programs. Nigel gained his bachelor’s degree in enterprise finance from Texas Condition University. 

Q: In 3 words and phrases or much less, how would you explain you?

Valerie: Ground breaking, resourceful, honest.

Mark Cuban has been taking on the drug industry, but which one?

Mark Cuban has been taking on the drug industry, but which one?

When billionaire Mark Cuban introduced his assault on the pharmaceutical marketplace and its high-priced medicines in January 2021, it was achieved with cheers.

His new corporation — the Mark Cuban Price tag As well as Drug Co., identified as Charge Additionally Medications — has the “lowest prices on meds anywhere,” he mentioned.

The serial entrepreneur and owner of the NBA’s Dallas Mavericks made the media rounds evangelizing, getting press by way of The Wall Street Journal, Time, “The Everyday Show,” and numerous other retailers. He gave colorful quotes alongside the way, at a person level declaring his aim is to “Just f— up the pharmaceutical market so undesirable that they bleed.”

His new organization, which at this time features more than a thousand generic remedies, has social media influencers singing his praises: Actuality star Kim Kardashian both equally tweeted and Instagrammed kudos. Former basketballer and Twitter personality Rex Chapman explained Cuban was “changing the match of prescription drug selling prices in The usa.”

Even a swinger’s forum on Reddit finds substantially to like about the company’s very low price ranges for Viagra and other meds.

Yet beneath the hype lies a murky truth: In lots of scenarios, the value estimates that people see on the web site are higher than they’d get at their regional pharmacy. It has to do with the segment Cuban is enjoying in — generic drugs — but also the layers of complexity peculiar to the American overall health program.

Suitable now, his enterprise principally sells generics, medication that are no extended protected by patents that could be certain monopoly earnings for huge pharmaceutical organizations. In most circumstances, it is the most affordable-priced section of the pharma overall economy.

To take a look at a substantial slice of Cuban’s wares, KHN appeared at all the medicines and solutions offered on his web page that start off with the letter “A,” with just about every mixture of strength, depend, or amount, and variety of medication (e.g., capsule, tablet, or chewable gummies) readily available. It’s a sizable sample: As of early February, it amounted to 211 combos.

KHN in comparison the price ranges for each range of medicine to the price ranges from other pharmacies for that similar medication, as compiled by comparison-shopping discount web-site GoodRx. Concentrating on the Washington, D.C., space, exactly where KHN is primarily based, the publication found decreased costs in at least a single pharmacy on GoodRx — which does not include things like Cuban’s business in its comparisons — in 141 occasions.

it-pays-to-shop-around-for-prescription-drugs (1).png

In the remaining 70 occasions, Cuban’s operation had reduce rates or was bested only by a person-time presents. Where there ended up financial savings, they could be substantial. A Washingtonian getting aprepitant, an anti-nausea medicine, could help you save hundreds of dollars applying Cuban’s internet site.

The analysis was not thorough, as Cuban pointed out to KHN by e mail. In aspect, that is simply because of the company’s pricing design: a 15{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} markup over manufacturers’ fees, as well as $3 for labor per drug and $5 to ship each and every order.

Numerous generics are so low-cost that the $5 delivery charge would swallow any little personal savings. Even now, Cuban observed, bundling numerous medication — all with 1 $5 delivery charge — could close up becoming more cost-effective in general.

Other regions of the state could possibly have fewer favorable pricing. When presented with KHN’s assessment, Cuban considered value comparisons may be much better in other places. “Maybe in DC they were providing a Pleased Hour specific :),” he wrote, with hooked up screenshots comparing his site’s pricing of both 10 and 40 milligrams’ dosage of atorvastatin, a common cholesterol drug, with the value at a CVS in Dallas. (But browsing in Dallas did not expose improved results: There was at least a single on line or brick-and-mortar possibility for every dosage and amount with decrease price ranges than Cuban’s enterprise.)

So why are the prices not essentially decrease on Cuban’s web-site than elsewhere? It’s owing to the peculiarities of the overall health care sector. Though his Twitter bio declares he’s “dunking on the pharma market,” what Cuban means is not what most persons believe he usually means.

“I look at our level of competition not truly so considerably as the precise generic pharmaceutical suppliers by themselves,” Value Furthermore Medicine co-founder Dr. Alex Oshmyansky stated in a podcast about pharmacies from March 2021.

Without a doubt, Oshmyansky said, they’re competing with pharmacy gain administrators and wholesalers.

Cuban’s wager so significantly, consequently, is significantly less that drug brands are inflating charges than that the businesses in in between — PBMs, wholesalers, and pharmacies — are.

And that wager is fewer most likely to fork out off for Cuban. Here’s why: PBMs negotiate prices above a basket of medications for their shoppers — insurers and employers. They check out to obtain a overall drug-invest quantity for each member of every single system. Optimizing the charge of every drug for every single affected person is not necessarily their target.

So PBMs take rebates from pharmaceutical firms and use other tactics that minimize investing (in idea) devoid of necessarily minimizing the rate of personal drugs. Pharmacies, in change, contract with several PBMs.

The value supplied by PBMs can change — working day to day, in some cases. Which is why organizations like GoodRx (which aggregates costs throughout several outlets) and some unbiased pharmacies (which can acquire medicines from wholesalers searching for greater quantity) can opportunistically give far better price ranges on picked generics. It’s also why considerably decreasing overall drug devote is difficult.

Other substantial providers are striving other charge-lowering strategies. Amazon, for case in point, has released a membership company for associates of its Prime club that delivers for unlimited accessibility to 53 generic remedies. There’s significant overlap among Amazon’s and Cuban’s checklist. If Amazon’s clout worries Cuban, he’s not expressing so. “I will not communicate on the document about rivals,” he advised KHN.

It’s widespread for massive shops — like Walmart — to offer you lower, fastened selling prices for quite a few generics. There are also startups, like one particular known as Renee, that present subscription solutions for generics.

Cuban’s enterprise occupies an uncommon niche in the marketplace. It is not a pharmacy — it relies on Truepill, a digital mail-buy enterprise, for these companies. It is also not a PBM — nevertheless it has partnered with a couple of.

Value Additionally Medication has begun the approach of creating its have manufacturing unit for generics, but correct now critics surprise no matter if it is seriously changing the supply chain. “They do not achieve their mission of eradicating the middlemen as they do not nonetheless manufacture anything at all and do not operate their personal pharmacy, i.e., they are only middlemen,” concluded Kyle McCormick, who operates an unbiased pharmacy that also delivers cash costs based mostly on a comparable markup over the price of the drugs.

“It frustrates me that they assert to be innovating when all they are presently doing is accomplishing factors slightly much better than incumbents,” he claimed.

Cuban generally demonizes his rivals, GoodRx CEO Doug Hirsch claimed. “He’s a Tv set individuality and he does a good job at bottling the anger that individuals have,” he said, just before conceding he was glad Cuban was in the marketplace.

In fact, the media blitz is a important component in the company’s results so significantly. Cuban has explained his enterprise does not expend income on marketing. Some credit rating the dimension of his Twitter following (approximately 9 million accounts) or his capability to generate news protection. Cuban credits phrase-of-mouth.

Although patients’ feedback on social media are commonly favorable, there are exceptions — and revealing kinds. Elisabeth Bitros, a Generation X nurse’s aide from New Jersey, mentioned she switched antidepressants to Cost Additionally Medicine right after her brick-and-mortar pharmacy attempted to charge her hundreds of dollars. But Cuban’s corporation wasn’t ideal either, she explained. A glitch delayed the refills for her antidepressant around the 2022 vacation season.

“This treatment, you start out to withdraw if you miss out on a dose,” she mentioned. “I will not want to go by way of the holidays withdrawing!” But receiving shopper company from Cost Additionally Medications was difficult: It was difficult to get hold of an individual by telephone. “It was all completed electronically,” she claimed. Right after a number of days of tag-teaming the service with her doctor, she went back again to CVS.

Cuban declined to comment on Bitros’ case precisely on the history, but wrote: “We consider to be incredibly transparent about the truth that although we have operators that are offered and we are always looking for exceptions that have to have personalized consideration and increasing our help, we is not going to be the speediest or best contact source.”

Cuban concluded: “That’s just a reality that comes with getting the low-charge company.”

KHN (Kaiser Well being Information) is a nationwide newsroom that produces in-depth journalism about health difficulties. Jointly with Policy Investigation and Polling, KHN is just one of the a few main functioning packages at KFF (Kaiser Relatives Foundation). KFF is an endowed nonprofit group supplying facts on wellness issues to the country.

Copyright 2023 Wellbeing News Florida

Diathrive Health and Mark Cuban Cost Plus Drug Company Announce New Collaboration

Diathrive Health and Mark Cuban Cost Plus Drug Company Announce New Collaboration

SALT LAKE City and DALLAS, Feb. 20, 2023 /PRNewswire/ — Diathrive Wellbeing, a diabetic issues and chronic disorder administration remedy, and Mark Cuban Price tag Plus Drug Company, PBC (“Charge Plus Medicine”), have declared a new collaboration now, focused on improving health care obtain, decreasing fees, and improving results for people living with diabetic issues and other chronic conditions.

“As a training medical doctor I noticed initially-hand the hazard of clients not currently being in a position to afford to pay for remedies and supplies,” mentioned Alex Oshmyansky, CEO of Mark Cuban Expense Plus Drug Company. “I established the Mark Cuban Price Furthermore Drug Corporation to help solve this dilemma and offer a way for individuals to acquire their therapies at an affordable selling price. We presently provide clear, small costs to funds-shell out people and are energized to now be operating with a business like Diathrive Overall health to even further lessen the value to clients, and to hold the affected individual history complete from equally a scientific and money perspective.”

“Long-term ailments like diabetes are advanced. The partnership with Price tag Furthermore Medicines will give our prospects an additional piece of the puzzle. Diathrive Well being is content to operate with a organization and workforce who share our aims and values,” said Michael Hennessy, Founder and CEO of Diathrive Health and fitness.

Expense In addition Medicines and Diathrive Wellness are both market disruptors. The romantic relationship will give shoppers lower charge remedies and diabetic issues screening materials and much more customized, increased high-quality treatment so that they can accomplish greater health and fitness results.

Diathrive Wellbeing eliminates the financial, administrative and psychosocial boundaries to taking care of a chronic condition. Associates get limitless diabetic issues screening provides, scientific aid from nurses who are Qualified Diabetic issues Treatment and Education Experts (CDCES) and access to the Diathrive Overall health application that enables users to self-teach and train themselves on how to take care of their issue.

About Mark Cuban Expense In addition Drug Firm

The Mark Cuban Cost In addition Drug Company, PBC (Value In addition Prescription drugs) aims to basically improve the way the pharmaceutical sector operates. As a general public-benefit company, its social mission of increasing general public overall health is just as important as the bottom line. Price tag In addition Medications transparently fees a normal markup on each drug it sells. The costplusdrugs.com on the web pharmacy introduced in January 2022 now carries around 1,000 prescription solutions, shipped by mail to thousands of content prospects each day. Expense Moreover Medicine is working with wellness programs, managed-treatment businesses, pharmacy positive aspects professionals (PBMs) and self-insured companies to carry these identical discounts to employer-sponsored advantage plans nationwide. https://www.linkedin.com/business/costplusdrugs/

About Diathrive Wellbeing

Diathrive Health’s solution gives people the highest high-quality option at the cheapest price tag. Users get endless glucose tests materials, time with nurses who are Licensed Diabetic issues Care and Schooling Experts (CDCES) and limitless use of the Diathrive Overall health app wherever they can deal with their data, find out about diabetic issues and hook up with a clinician.

Through its Overall health Advisor alternative, Diathrive Well being is preserving businesses up to 85{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} on their diabetes wellness positive aspects and supporting customers obtain far better wellbeing outcomes.

Diathrive Health and fitness was a short while ago awarded highest-amount validation for healthcare personal savings from the Validation Institute.

Master additional about Diathrive Health and fitness.

Source Diathrive Well being

Mark Cuban Has Been Taking On the Drug Industry. But Which One?

Mark Cuban Has Been Taking On the Drug Industry. But Which One?

When billionaire Mark Cuban announced his assault on the pharmaceutical business and its substantial-priced medicine in January 2021, it was satisfied with cheers.

His new company — the Mark Cuban Charge As well as Drug Co., recognised as Cost Additionally Drugs — has the “lowest price ranges on meds any place,” he said.

The serial entrepreneur and operator of the NBA’s Dallas Mavericks built the media rounds evangelizing, having press by way of The Wall Street Journal, Time, “The Everyday Clearly show,” and lots of other outlets. He gave colorful quotes along the way, at 1 issue declaring his objective is to “Just f— up the pharmaceutical business so negative that they bleed.”

His new enterprise, which presently offers over a thousand generic prescription drugs, has social media influencers singing his praises: Reality star Kim Kardashian equally tweeted and Instagrammed kudos. Previous basketballer and Twitter temperament Rex Chapman mentioned Cuban was “changing the video game of prescription drug charges in The usa.”

Even a swinger’s forum on Reddit finds a lot to like about the company’s small costs for Viagra and other meds.

Yet beneath the buzz lies a murky fact: In numerous conditions, the price estimates that patients see on the web page are better than they’d get at their local pharmacy. It has to do with the segment Cuban is playing in — generic medication — but also the levels of complexity peculiar to the American health and fitness method.

Suitable now, his enterprise mostly sells generics, medications that are no longer guarded by patents that could be certain monopoly revenue for significant pharmaceutical organizations. In most instances, it is the lowest-priced component of the pharma economic climate.

To examine a considerable slice of Cuban’s wares, KHN appeared at all the prescription drugs and solutions available on his site that start out with the letter “A,” with each blend of toughness, count, or amount, and form of medicine (e.g., capsule, pill, or chewable gummies) obtainable. It is a sizable sample: As of early February, it amounted to 211 mixtures.

KHN when compared the prices for every single wide variety of treatment to the rates from other pharmacies for that same medicine, as compiled by comparison-shopping low cost website GoodRx. Concentrating on the Washington, D.C., location, exactly where KHN is primarily based, the publication discovered reduced price ranges in at least a person pharmacy on GoodRx — which does not contain Cuban’s firm in its comparisons — in 141 circumstances.

In the remaining 70 cases, Cuban’s procedure experienced lower costs or was bested only by one-time offers. Where by there were being personal savings, they could be considerable. A Washingtonian getting aprepitant, an anti-nausea medication, could conserve hundreds of dollars utilizing Cuban’s site.

The examination was not extensive, as Cuban pointed out to KHN by electronic mail. In aspect, which is since of the company’s pricing product: a 15{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} markup more than manufacturers’ fees, additionally $3 for labor per drug and $5 to ship every order.

Numerous generics are so affordable that the $5 shipping price would swallow any tiny price savings. Nonetheless, Cuban pointed out, bundling several prescription drugs — all with 1 $5 shipping and delivery cost — could conclusion up getting more affordable over-all.

Other regions of the place could possibly have less favorable pricing. When presented with KHN’s investigation, Cuban imagined cost comparisons may be far better somewhere else. “Maybe in DC they had been providing a Delighted Hour specific :),” he wrote, with hooked up screenshots evaluating his site’s pricing of equally 10 and 40 milligrams’ dosage of atorvastatin, a common cholesterol drug, with the charge at a CVS in Dallas. (But searching in Dallas did not expose improved final results: There was at the very least just one on the internet or brick-and-mortar possibility for each and every dosage and quantity with decrease costs than Cuban’s corporation.)

So why are the rates not always lower on Cuban’s web page than somewhere else? It is thanks to the peculiarities of the health treatment sector. Though his Twitter bio declares he’s “dunking on the pharma sector,” what Cuban indicates is not what most folks feel he signifies.

“I perspective our competitors not definitely so significantly as the actual generic pharmaceutical suppliers on their own,” Value Furthermore Drugs co-founder Dr. Alex Oshmyansky mentioned in a podcast about pharmacies from March 2021.

Without a doubt, Oshmyansky stated, they’re competing with pharmacy benefit managers and wholesalers.

Cuban’s bet so considerably, for that reason, is less that drug brands are inflating costs than that the firms in concerning — PBMs, wholesalers, and pharmacies — are.

And that guess is less very likely to spend off for Cuban. Here’s why: PBMs negotiate fees about a basket of medicine for their purchasers — insurers and companies. They consider to attain a full drug-devote variety for each member of each and every approach. Optimizing the expense of every single drug for each affected individual is not essentially their intention.

So PBMs acknowledge rebates from pharmaceutical organizations and use other procedures that decrease shelling out (in theory) with no always cutting down the rate of specific medicines. Pharmacies, in flip, contract with many PBMs.

The value supplied by PBMs can differ — working day to day, at times. Which is why companies like GoodRx (which aggregates prices across several shops) and some independent pharmacies (which can purchase medications from wholesalers searching for higher volume) can opportunistically provide better selling prices on picked generics. It is also why noticeably reducing whole drug expend is tricky.

Other huge firms are making an attempt other cost-decreasing strategies. Amazon, for case in point, has released a subscription service for members of its Key club that gives for limitless access to 53 generic drugs. There is significant overlap involving Amazon’s and Cuban’s record. If Amazon’s clout anxieties Cuban, he’s not stating so. “I won’t converse on the document about opponents,” he advised KHN.

It is widespread for massive stores — like Walmart — to give very low, fastened price ranges for several generics. There are also startups, like a person named Renee, that supply subscription services for generics.

Cuban’s company occupies an abnormal market in the market place. It is not a pharmacy — it depends on Truepill, a digital mail-buy firm, for all those providers. It is also not a PBM — however it has partnered with a handful of.

Value Plus Prescription drugs has started the method of creating its own manufacturing unit for generics, but appropriate now critics question irrespective of whether it is truly altering the provide chain. “They do not attain their mission of doing away with the middlemen as they do not nevertheless manufacture nearly anything and do not run their personal pharmacy, i.e., they are only middlemen,” concluded Kyle McCormick, who runs an impartial pharmacy that also features hard cash selling prices centered on a equivalent markup over the price tag of the drugs.

“It frustrates me that they assert to be innovating when all they are at this time carrying out is carrying out items a little better than incumbents,” he stated.

Cuban often demonizes his competitors, GoodRx CEO Doug Hirsch stated. “He’s a Television set character and he does a excellent position at bottling the anger that shoppers have,” he mentioned, prior to conceding he was glad Cuban was in the industry.

Indeed, the media blitz is a vital component in the company’s accomplishment so considerably. Cuban has explained his firm does not devote income on marketing and advertising. Some credit history the size of his Twitter next (just about 9 million accounts) or his ability to earn information protection. Cuban credits term-of-mouth.

Whilst patients’ responses on social media are frequently favorable, there are exceptions — and revealing types. Elisabeth Bitros, a Technology X nurse’s aide from New Jersey, explained she switched antidepressants to Charge Moreover Medication immediately after her brick-and-mortar pharmacy attempted to demand her hundreds of pounds. But Cuban’s organization was not fantastic both, she mentioned. A glitch delayed the refills for her antidepressant all-around the 2022 holiday break year.

“This treatment, you start off to withdraw if you miss a dose,” she claimed. “I never want to go by way of the holidays withdrawing!” But receiving buyer provider from Charge As well as Medicine was difficult: It was hard to get maintain of another person by cellphone. “It was all carried out electronically,” she reported. Soon after a couple times of tag-teaming the assistance with her health care provider, she went back again to CVS.

Cuban declined to comment on Bitros’ situation precisely on the record, but wrote: “We try out to be very transparent about the fact that while we have operators that are accessible and we are generally on the lookout for exceptions that require private interest and bettering our aid, we would not be the fastest or highest contact source.”

Cuban concluded: “That’s just a fact that comes with currently being the reduced-charge supplier.”

Related Topics

Speak to Us

Post a Story Tip

GM Tops Q4 Earnings Mark, Ford Misses & More

GM Tops Q4 Earnings Mark, Ford Misses & More

Last week, many auto biggies released U.S. vehicle sales data for January 2023. Among the automakers that revealed monthly sales numbers, Honda, Ford, Mazda, Hyundai, Kia, Subaru and Volvo registered year-over-year gains, while Toyota posted a decline in sales. Per Motor Intelligence, the seasonally adjusted annualized rate of sales reached 16.21 million last month, marking the best level since May 2021. Per LMC Automotive, U.S. light vehicle sales totaled 1.04 million units in January, up 4.5{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} year over year. But lest we forget, January 2022 was the first January since 2012 that couldn’t record vehicle sales of even 1 million units amid severe supply chain issues. While sales in the last month rose year over year, it’s certainly not a sign that the auto industry is rebounding to pre-pandemic levels. In fact, January 2023 recorded the weakest vehicle sales since 2014 if we exclude January 2022 sales data.

Meanwhile, a host of auto players released fourth-quarter results last week. U.S. legacy automaker General Motors GM beat earnings estimates, while its cross-town rival Ford F missed the same.  U.S. motorcycle giant Harley-Davidson HOG, auto retailer Asbury Automotive ABG and automotive equipment provider Lear Corporation LEA surpassed fourth-quarter earnings estimates.

GM, F, HOG, ABG and LEA carry a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Snapshot of Last Week’s Key Earnings Releases

General Motors reported fourth-quarter 2022 adjusted earnings of $2.12 per share, surpassing the Zacks Consensus Estimate of $1.68. Higher-than-expected revenues and profit from the North America segment led to the outperformance. The bottom line also surged from the year-ago quarter’s earnings of $1.35 per share. Revenues of $43,108 million beat the Zacks Consensus Estimate of $41,313 million. The top line soared 28.3{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} from the year-ago figure of $33,584 million. The company recorded adjusted earnings before interest and taxes (EBIT) of $3,799 million, higher than $2,839 million in the prior-year quarter.

General Motors had cash and cash equivalents of $19,153 million as of Dec 31, 2022, compared with $20,067 million as of Dec 31, 2021. The long-term automotive debt at the end of the quarter was $15,885 million compared with $16,355 million as of Dec 31, 2021. General Motors’ automotive cash provided by operating activities amounted to $7,488 million during the quarter under review, down 20.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} year over year.  The company recorded an adjusted automotive free cash flow of $4,460 million in fourth-quarter 2022, down 30.3{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} year over year. (General Motors Q4 Earnings Beat on GMNA Unit Strength)

Ford reported adjusted earnings of 51 cents per share in fourth-quarter 2022, missing the Zacks Consensus Estimate of 60 cents. Lower-than-expected profits from all but International Markets Group unit led to this downslide. The bottom line improved 96.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} from the year-ago quarter’s earnings of 26 cents. The company’s consolidated fourth-quarter revenues came in at $44 billion, rising 17{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} year over year. Revenues from Ford Automotive segment increased 18{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} to $41.8 billion and surpassed the Zacks Consensus Estimate of $39.4 billion.

Ford reported an adjusted FCF of $2.4 billion during the quarter. It had cash and cash equivalents of $25,134 million as of Dec 31, 2022, compared with $20,540 million on Dec 31, 2021. Long-term debt excluding Ford Credit totaled $19.2 billion at the end of 2022, up from $17.2 billion as of Dec 31, 2021. Adjusted EBIT for 2023 is estimated to be in the range of $9 billion – $11 billion. Adjusted FCF is envisioned to be $6 billion. Along with the regular first-quarter dividend of 15 cents per, Ford declared a supplemental dividend of 65 cents per share, aided by robust FCF. (Ford Q4 Earnings Miss Estimates, Sales Grow 17{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} Y/Y)

Harley-Davidson reported fourth-quarter 2022 adjusted earnings of 28 cents per share, beating the Zacks Consensus Estimate of 3 cents. Higher-than-anticipated revenues from the Motorcycles & Related Products and Financial Services segments resulted in this outperformance. The bottom line also shot up 100{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} from 14 cents per share reported in the year-ago quarter. The motorcycle manufacturer generated consolidated revenues (including motorcycle sales and financial services revenues) of $1,142 million, up 12{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} from the year-earlier quarter.

Harley-Davidson had cash and cash equivalents of $1.4 billion as of Dec 31, 2022, down from $1.8 billion as of Dec 31, 2021. In the same period, the long-term debt decreased to $4,457 million from $4,595.6 million recorded on Dec 31, 2021. For 2023, the company expects revenues from the motorcycles segment to grow in the band of 4{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}-7{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. The operating income margin expectation for the motorcycles segment is in the range of 14.1{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} to 14.6{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. HOG expects its operating income for Financial Services to decline by 20-25{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b}. Capital expenditure projection for the full year is in the range of $225-$250 million. (Harley-Davidson’s Q4 Earnings Breeze Past Estimates)

Lear reported fourth-quarter 2022 adjusted earnings of $2.81 per share, surging from $1.22 recorded in the year-ago quarter. The bottom line also surpassed the Zacks Consensus Estimate of $2.54 per share. Higher-than-expected earnings across both business segments led to the outperformance. In the reported quarter, revenues increased 10{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} year over year to $5,370.9 million. The top line also beat the Zacks Consensus Estimate of $5,226 million.

The company had $1,114.9 million in cash and cash equivalents at the quarter’s end versus $1,318.3 million recorded as of Dec 31, 2021. Lear had long-term debt of $2,591.2 million at quarter end, lower than a debt of $2,595.2 million as of 2021-end.Lear projects full-year net sales in the band of $21,200-$22,200 million, up from $20,891 million recorded in 2022. Core operating earnings are envisioned in the range of $875-$1,075 million, implying an uptick from $871 generated in 2022. Operating cash flow is projected within $1,075-$1,225 million. Lear anticipates FCF in the band of $375-$525 million. Capital spending forecast is $700 million. Adjusted EBITDA is envisioned within the range of $1,475-$1,675 million. (Lear Q4 Earnings Surpass Estimates, ’23 View Upbeat)

Asbury reported impressive fourth-quarter 2022 adjusted earnings of $9.12 per share, which increased 22.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} year over year and topped the Zacks Consensus Estimate of $8.23 per share. This outperformance can be primarily attributed to higher-than-expected gross profit from the new vehicle and finance & insurance units. In the reported quarter, revenues amounted to $3.7 billion, surging 40{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} year over year. The top line, however, fell short of the Zacks Consensus Estimate of $3.8 billion.

As of Dec 31, 2022, the company had cash and cash equivalents of $235.3 million, up from $178.9 million on Dec 31, 2021. It had long-term debt of $3,301.2 million as of Dec 31, 2022, down from $3,582.6 million on Dec 31, 2021. During 2022, Asbury repurchased approximately 1.6 million shares for nearly $300 million. During the last reported quarter, the company adopted a Rule 10b5-1 trading plan, effective for trading Dec 19, 2022, through Feb 1, 2023. From Oct 1, 2022 through Feb 1, 2023, the company repurchased around 600,000 shares for $108 million. On Jan 26, 2023, Asbury boosted its share repurchase authorization to $200 million. As of Feb 1, the company had $200 million share repurchase authorization remaining. (Asbury Q4 Earnings Outstrip Estimates, Jump 22.2{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} Y/Y)

Price Performance

The following table shows the price movement of some of the major auto players over the last week and six-month period.

Zacks Investment Research

Zacks Investment Research

Image Source: Zacks Investment Research

What’s Next in the Auto Space?

Industry watchers will track China vehicle sales data for January 2023, which is likely to be released by the China Association of Automobile Manufacturers this week. Also, stay tuned for the quarterly results of major S&P 500 sector companies like O’Reilly and BorgWarner, which will report soon.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Ford Motor Company (F) : Free Stock Analysis Report

Harley-Davidson, Inc. (HOG) : Free Stock Analysis Report

General Motors Company (GM) : Free Stock Analysis Report

Lear Corporation (LEA) : Free Stock Analysis Report

Asbury Automotive Group, Inc. (ABG) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Mark Cuban’s Cost Plus Drugs could have saved his NBA team almost $150,000 on medications

Mark Cuban’s Cost Plus Drugs could have saved his NBA team almost $150,000 on medications

Almost a calendar year back, Mark Cuban, the billionaire proprietor of the Dallas Mavericks and superstar trader on ABC’s Shark Tank, introduced an on line pharmacy promising affordable costs on prescription drugs.

He kept to his assure.

Mark Cuban talked with moderator Emily Ramshaw, co-founder and CEO of The 19th News, in the course of the once-a-year Dallas Regional Chamber meeting Jan. 17, 2023, at the Winspear Opera Household in Dallas.

The Mark Cuban Expense Furthermore Drug Co. has simplified items for approximately 2 million consumers, Cuban told a packed crowd at the Dallas Regional Chamber’s 2023 once-a-year conference Tuesday. The only firm Cuban has ever put his identify on sells medications at a flat 15{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} markup, a $3 pharmacist cost and a $5 rate for shipping.

“Sometimes disruption is just about simplifying,” he reported. “The pharmaceutical business has just morphed into a extremely intricate sector.”

The business cuts out middlemen and negotiates straight with drug suppliers and pharmacies for rebates and bargains on behalf of businesses, health insurers and govt wellbeing programs. He stated Price As well as has by now signed discounts with a several unbiased pharmacies in Dallas and other metropolitan areas.

“It took out all the mystery of how medicines are priced,” Cuban mentioned.

It is a strategy that could help you save funds for even an NBA workforce like his Dallas Mavericks.

Mavs CEO Cynt Marshall compiled a list of the generic prescription drugs priced in excess of $30 that the crew acquired in 2021 and 2022. The workforce expended $165,000. If the staff had purchased by way of Value Furthermore, it would have price tag $19,000, Cuban stated.

He also pointed to the Harvard University report released in June that concluded Medicare could have saved $3.6 billion in a solitary yr if it experienced acquired generic drugs from the on the web pharmacy. And he talked about clients who go on his Twitter account to thank him for their personal personal savings.

Mark Cuban has Vegas-like vision for Dallas, new Mavs arena if Texas OKs on line casino gambling

Cuban’s entry into prescribed drugs commenced with an frequently-informed tale about a “cold email” he bought from Alex Oshmyansky seeking to commence a little compounding pharmacy. Which is exactly where Cuban figured out about the industry. Oshmyansky co-started the business with Cuban and is now its CEO.

Collectively, the two have been developing a 22,000-sq.-foot plant in Dallas’ Deep Ellum community to manufacture drugs. The facility is predicted to be done early this year.

Getting on major pharma would intimidate most other individuals. Cuban explained he does not consider there is any field that can not be disrupted. He traces his philosophy to his roots escalating up in Pittsburgh, a gritty metal city at the time which is due to the fact been reborn.

“I’ve just been a hustler my full life,” he said. “Whenever somebody advised me I couldn’t do anything, I think I obtained the most joy out of proving them improper. From that point on, it was often hoping to find a way to do items that other folks weren’t undertaking and do it initial. ”

Mark Cuban’s essential to results: ‘Somebody’s acquired to be the luckiest guy’